CGP-43371

• Description :

  CGP-43371, a Rifampicin (HY-B0272) derivative, is an orally active hypolipidemic agent. CGP-43371 has hypolipidemic and anti-atherosclerotic activities[1].

• UNSPSC :

  12352005

• Target :

  Drug Derivative

• Related Pathways :

  Others

• Field of Research :

  Cardiovascular Disease

• Smiles :

  O=C(C(C)(C)C)OC(C(C(OC(/C(C)=C\C=C\[C@@H]([C@@H]([C@H]1C)O)C)=N2)=C2C(N3CCN(CC(C(C)=CC(C)=C4)=C4C)CC3)=C5O)=C5C6=C7O[C@](C)(O/C=C/[C@@H]([C@H]([C@@]([C@H](C)[C@@H]1O)([H])OC(C)=O)C)OC)C6=O)=C7C

• Molecular Formula :

  C56H73N3O12

• Molecular Weight :

  980.19

• References & Citations :

  [1]Feldman DL, et al. CGP 43371 paradoxically inhibits development of rabbit atherosclerotic lesions while inducing extra-arterial foam cell formation. Atherosclerosis. 2001 Feb 1;154 (2) :317-28.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [123036-23-7]